Literature DB >> 1313504

Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome.

I J Russell1, J E Michalek, G A Vipraio, E M Fletcher, M A Javors, C A Bowden.   

Abstract

The density of serotonin reuptake receptors on peripheral platelets from 22 patients with primary fibromyalgia syndrome (FS) and the serum serotonin concentrations in 9 patients with FS were compared with those of matched healthy controls. The mean serum serotonin concentration was lower (p = 0.01) in FS than in controls, while the binding of 3H-imipramine was higher (p = 0.035) and normalized with treatment using a combination of ibuprofen and alprazolam. Improvement in selected clinical measures of FS disease activity during treatment correlated with the change in platelet 3H-imipramine binding. These findings support the proposed hypothesis of aberrant pain perception in FS resulting from a deficiency of serotonin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313504

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  41 in total

Review 1.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

2.  Serum serotonin levels are not useful in diagnosing fibromyalgia.

Authors:  Gabriel Jaschko; Urs Hepp; Magdalena Berkhoff; Margrit Schmet; Beat A Michel; Steffen Gay; Haiko Sprott
Journal:  Ann Rheum Dis       Date:  2007-09       Impact factor: 19.103

3.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 4.  Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.

Authors:  L A Bradley; N L McKendree-Smith; G S Alarcón
Journal:  Curr Rev Pain       Date:  2000

Review 5.  Chronic pain syndromes.

Authors:  S Carette
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

6.  The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome.

Authors:  D M See; P Cimoch; S Chou; J Chang; J Tilles
Journal:  Integr Physiol Behav Sci       Date:  1998 Jul-Sep

Review 7.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

8.  A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

Authors:  Amy S Chappell; Laurence A Bradley; Curtis Wiltse; Michael J Detke; Deborah N D'Souza; Michael Spaeth
Journal:  Int J Gen Med       Date:  2008-11-30

Review 9.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  The fibromyalgia family study: a genome-wide linkage scan study.

Authors:  Lesley M Arnold; Jinbo Fan; I Jon Russell; Muhammad B Yunus; Muhammad Asim Khan; Irving Kushner; Jane M Olson; Sudha K Iyengar
Journal:  Arthritis Rheum       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.